Concepedia

Shyeilla V. Dhuria

SV

14

Publications

851

Citations

13

H-Index

2008

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Massachusetts General Hospital

Sarah Cannon

Tennessee Oncology

Shyeilla V. Dhuria is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and cancer research.

Top concepts

Publications per year

2008–2023

14

Publications

14

Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors

Jeffrey R. Infante, E. Claire Dees, Anthony J. Olszanski et al. · Journal of Clinical Oncology · 2014 · 205 citations · Full text

Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system

Shyeilla V. Dhuria, Leah R. Hanson, William H. Frey · Journal of Pharmaceutical Sciences · 2008 · 133 citations

, , +9

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study

Giuseppe Curigliano, P. Gómez Pardo, Funda Meric‐Bernstam et al. · The Breast · 2016 · 132 citations · Full text

Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System

Shyeilla V. Dhuria, Leah R. Hanson, William H. Frey · Journal of Pharmacology and Experimental Therapeutics · 2008 · 98 citations

Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: <i>In Silico</i> and Clinical Evaluations

Tanay S. Samant, Shyeilla V. Dhuria, Yasong Lu et al. · Clinical Pharmacology & Therapeutics · 2017 · 77 citations · Full text

Rows per page

1–5 of 14